Sweden and India have a long tradition of cooperation in the field of health and life sciences. From a cooperation based on development aid, the collaboration has evolved to a more dynamic and mutually beneficial alliance. Sweden has much to offer India when it comes to organizing healthcare, for example when it comes to creating a strong system for obstetrics and pediatrics, gerontological nursing and offering universal coverage. Meanwhile India is also emerging as a hub for cost-effective R&D and clinical trials. Could Indian and Swedish companies cooperate to find solutions in important areas of life sciences? This roundtable will focus on non-communicable diseases such as diabetes, cardio-vascular diseases and cancer. The focus will be on the business of science.

This session is moderated by Sanjeevi Carani, , Professor, Karolinska Institute

Speakers Participating in the Life Science & Innovation Roundtable are:

Anders Hektor, Deputy Director Ministry of Enterprise and Innovation

Annika Kollén, Director Supply Chain Operations, SOBI

Hans Wigzell, Karolinska Institute

Karim Cassimjee, Co-founder of EnginZyme AB

Lena Rondahl, Global Export Manager, Marketing and Sales, Sobi

Lina Andersson, Head of Global Sustainability, Meda AB

Dr. Rajiv Modi, Chairman and CEO of Cadila Pharmaceuticals

Robin Chatterjee, Co-founder of EnginZyme AB

Dr. Simone Ahuja, Author or Jugaad and founder of Bloodorange

Thomas Eldered, CEO of Recipharm AB

Ylva Wide, Vice President of Swecare

Åke Lindal, CEO of Zelmic, Lund, Sweden

Please note, all the roundtables are invitation only.